
Radiopharmaceutical Reimbursement Rates—Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 60 words of the full text and any section headings. |
|
 |
 |
In Reply: I appreciate Dr Singer's comments and agree that changes in Congress have occurred between the time that the news article was written and the time that it appeared in print. Congress has temporarily put a stop to cuts on radiotherapy reimbursements. It is unclear whether additional extensions or other actions will occur this summer.
Financial Disclosures: None reported.
Tracy Hampton, PhD
tracy.hampton@jama-archives.org JAMA Chicago, Illinois
Letters Section Editor: Robert M. Golub, MD, Senior Editor.
JAMA. 2008;299(21):2512-2513.
RELATED ARTICLE
Phase 3 Trials Suggest Ways to Improve Current Hematologic Cancer Therapies
Tracy Hampton
JAMA. 2008;299(5):510-512.
EXTRACT
| FULL TEXT
RELATED LETTER
Radiopharmaceutical Reimbursement Rates
Jack W. Singer
JAMA. 2008;299(21):2512.
EXTRACT
| FULL TEXT
|